Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in Alzheimer's disease: A principal components analysis

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 215-219

  Maas, Luis C ^a,b,c   Harris, Gordon J ^d   Satlin, Andrew ^a,b   English, Camper D ^a,b   Lewis, Robert F ^d   Renshaw, Perry F ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Cerebral blood volume; DSC MRI; Echo planar imaging; Principal component analysis

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CIRCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS; RADIOGRAPHIC IMAGE ENHANCEMENT; REFERENCE VALUES; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031421911     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070133     Document Type: Article

References (29)

1. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab 1985; 5:193-200.
2. Friedland RP, Jagust WJ, Huesman RH, et al. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology 1989; 39:1427-1434.
3. Ichimiya A, Herholz K, Mielke R, Kessler J, Slansky I, Heiss W-D. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study. J Neurol Sci 1994; 123:11-17.
4. Alexander GE, Moeller JR, Grady CL, Pietrini P, Mentis MJ, Schapiro MB. Association of cognitive functions with regional networks of brain metabolism in Alzheimer's disease. Neurobiol Aging 1994; 15(suppl 1):S36.
5. Komatani A, Yamaguchi K, Sugai Y, et al. Assessment of demented patients by dynamic SPECT of inhaled xenon-133. J Nucl Med 1988; 29:1621-1626.
6. Hellman RS, Tikofsky RS, Collier BD, et al. Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging. Radiology 1989; 172:183-188.
7. Montaldi D, Brooks DN, McColl JH, et al. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1990; 53:33-38.
8. Harris GJ, Links JM, Pearlson GD, Camargo EE. Coritical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease. Psychiatry Res Neuroimaging 1991; 40:167-180.
9. Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992; 13:483-491.
10. Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992; 49:402-408.
11. Syed GMS, Eagger S, O'Brien J, Barrett JJ, Levy R. Patterns of regional cerebral blood flow in Alzheimer's disease. Nucl Med Commun 1992; 13:656-663.
12. Engel P, Cummings JL, Villanueva-Meyer J, Mena I. Single photon emission computed tomography in dementia: relationship of perfusion to cognitive deficits. J Geriatr Psychiatry Neurol 1993; 6:144-151.
13. Hanyu H, Abe S, Arai H, Asano T, Iwamoto T, Takasaki M. Diagnostic accuracy of single photon emission computed tomography in Alzheimer's disease. Gerontology 1993; 39:260-266.
14. Johnson KA, Kijewski MF, Becker A, Garada B, Satlin A, Holman BL. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993; 34:2044-2048.
15. McKeith IG, Bartholomew PH, Irvine EM, Cook J, Adams R, Simpson AES. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia: regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry 1993; 163:597-603.
16. Sackeim HA, Prohovnik I, Moeller JR, Mayeux R, Stern Y, Devanand DP. Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med 1993; 34:1090-1101.
17. Talbot PR, Snowden JS, Lloyd JJ, Neary D, Testa HJ. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol 1995; 242:579-586.
18. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990; 14:538-546.
19. Harris GJ, Lewis RF, Satlin A, et al. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry 1996; 153:721-724.
20. Basilevsky A. Statistical factor analysis and related methods: theory and applications. New York: John Wiley & Sons, 1994; 97-346.
21. Clark C, Carson R, Kessler R, et al. Alternative statistical models for the examination of clinical positron emission tomography /fluorodeoxyglucose data. J Cereb Blood Flow Metab 1985; 5: 142-150.
22. Alexander GE, Moeller JR. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function and disease. Human Brain Mapping 1994; 2:79-94.
23. McKhann G, Drachman D, Folstein M, Katzman R. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 37:939-944.
24. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12:189-198.
25. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994; 21:503-508.
26. Jernigan TL, Salmon DP, Butters N, Hesselink JR. Cerebral structure on MRI. Part II: specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991; 29:68-81.
27. Murphy DG, DeCarli CD, Daly E, et al. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biol Psychiatry 1993; 34: 612-621.
28. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55:190-194.
29. Horwitz B. Data analysis paradigms for metabolic-flow data: combining neural modeling and functional neuroimaging. Human Brain Mapping 1994; 2:112-122.